BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 27288568)

  • 1. Ras signaling through RASSF proteins.
    Donninger H; Schmidt ML; Mezzanotte J; Barnoud T; Clark GJ
    Semin Cell Dev Biol; 2016 Oct; 58():86-95. PubMed ID: 27288568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RASSF effectors couple diverse RAS subfamily GTPases to the Hippo pathway.
    Dhanaraman T; Singh S; Killoran RC; Singh A; Xu X; Shifman JM; Smith MJ
    Sci Signal; 2020 Oct; 13(653):. PubMed ID: 33051258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RASSF family proteins and Ras transformation.
    Vos MD; Clark GJ
    Methods Enzymol; 2006; 407():311-22. PubMed ID: 16757334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NORE1A is a double barreled Ras senescence effector that activates p53 and Rb.
    Donninger H; Barnoud T; Clark GJ
    Cell Cycle; 2016 Sep; 15(17):2263-4. PubMed ID: 26919075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel type of Ras effector interaction established between tumour suppressor NORE1A and Ras switch II.
    Stieglitz B; Bee C; Schwarz D; Yildiz O; Moshnikova A; Khokhlatchev A; Herrmann C
    EMBO J; 2008 Jul; 27(14):1995-2005. PubMed ID: 18596699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RASSF1A Deficiency Enhances RAS-Driven Lung Tumorigenesis.
    Schmidt ML; Hobbing KR; Donninger H; Clark GJ
    Cancer Res; 2018 May; 78(10):2614-2623. PubMed ID: 29735543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the NORE1A tumor suppressor in Oncogene-Induced Senescence.
    Barnoud T; Schmidt ML; Donninger H; Clark GJ
    Cancer Lett; 2017 Aug; 400():30-36. PubMed ID: 28455242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The RASSF1A tumor suppressor.
    Donninger H; Vos MD; Clark GJ
    J Cell Sci; 2007 Sep; 120(Pt 18):3163-72. PubMed ID: 17878233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NORE1A is a Ras senescence effector that controls the apoptotic/senescent balance of p53 via HIPK2.
    Donninger H; Calvisi DF; Barnoud T; Clark J; Schmidt ML; Vos MD; Clark GJ
    J Cell Biol; 2015 Mar; 208(6):777-89. PubMed ID: 25778922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nore1 and RASSF1 regulation of cell proliferation and of the MST1/2 kinases.
    Avruch J; Praskova M; Ortiz-Vega S; Liu M; Zhang XF
    Methods Enzymol; 2006; 407():290-310. PubMed ID: 16757333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ras-association domain family protein 6 induces apoptosis via both caspase-dependent and caspase-independent pathways.
    Ikeda M; Hirabayashi S; Fujiwara N; Mori H; Kawata A; Iida J; Bao Y; Sato Y; Iida T; Sugimura H; Hata Y
    Exp Cell Res; 2007 Apr; 313(7):1484-95. PubMed ID: 17367779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RASSF4/AD037 is a potential ras effector/tumor suppressor of the RASSF family.
    Eckfeld K; Hesson L; Vos MD; Bieche I; Latif F; Clark GJ
    Cancer Res; 2004 Dec; 64(23):8688-93. PubMed ID: 15574778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The RASSF1A tumor suppressor activates Bax via MOAP-1.
    Vos MD; Dallol A; Eckfeld K; Allen NP; Donninger H; Hesson LB; Calvisi D; Latif F; Clark GJ
    J Biol Chem; 2006 Feb; 281(8):4557-63. PubMed ID: 16344548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineered variants of the Ras effector protein RASSF5 (NORE1A) promote anticancer activities in lung adenocarcinoma.
    Singh A; Erijman A; Noronha A; Kumar H; Peleg Y; Yarden Y; Shifman JM
    J Biol Chem; 2021 Dec; 297(6):101353. PubMed ID: 34717958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic characterization of apoptotic Ras signaling through Nore1-MST1 complex formation.
    Koturenkiene A; Makbul C; Herrmann C; Constantinescu-Aruxandei D
    Biol Chem; 2017 May; 398(5-6):701-707. PubMed ID: 28141542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comprehensive analysis of RAS-effector interactions reveals interaction hotspots and new binding partners.
    Rezaei Adariani S; Kazemein Jasemi NS; Bazgir F; Wittich C; Amin E; Seidel CAM; Dvorsky R; Ahmadian MR
    J Biol Chem; 2021; 296():100626. PubMed ID: 33930461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RASSF6 is a novel member of the RASSF family of tumor suppressors.
    Allen NP; Donninger H; Vos MD; Eckfeld K; Hesson L; Gordon L; Birrer MJ; Latif F; Clark GJ
    Oncogene; 2007 Sep; 26(42):6203-11. PubMed ID: 17404571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ubiquitous activation of Ras and Jak/Stat pathways in human HCC.
    Calvisi DF; Ladu S; Gorden A; Farina M; Conner EA; Lee JS; Factor VM; Thorgeirsson SS
    Gastroenterology; 2006 Apr; 130(4):1117-28. PubMed ID: 16618406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rheb may complex with RASSF1A to coordinate Hippo and TOR signaling.
    Nelson N; Clark GJ
    Oncotarget; 2016 Jun; 7(23):33821-31. PubMed ID: 27034171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal cancer and RASSF family--a special emphasis on RASSF1A.
    Fernandes MS; Carneiro F; Oliveira C; Seruca R
    Int J Cancer; 2013 Jan; 132(2):251-8. PubMed ID: 22733432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.